CSL’s Response to COVID-19
Despite the constantly challenging environment the COVID-19 pandemic has presented to the world, CSL has remained steadfast in our promise to safeguarding our patients, our plasma donors and our employees. As the pandemic continues to evolve, so have we. CSL has redirected resources and taken on extra commitments to protect public health where we could offer the most value, including our expertise, technologies, equipment and materials. And through it all, we continue to deliver on our promise for those who need us most, our patients.Read More About CSL Behring's Efforts with COVID-19
Watch: CSL Explained in a Minute
A short animation gives an overview of CSL’s businesses and how they are driven by a promise – to patients and to protect pub…
The 60-40 Principle
Get career tips from CSL’s Jill Allen, who believes in taking a chance on yourself at work. Today, she’s Senior Director of B…
Watch Danielle's Story
Mom-to-be Danielle D. on overcoming her rare disease to live the life she has always envisioned.
Anatomy of a Heart Attack
What happens on the inside during a myocardial infarction (MI)? We follow the cascade of events.
Patients Thank Plasma Donors for Doing the Amazing
Meet three grateful patients who need plasma-derived medicines to manage their conditions.
Lessons from the Pool
Once a competitive swimmer, R&D’s Bronwyn Kingwell sees science as a sport of endurance and teamwork.
Rose Fida's Purpose Driven Career
In an interview with career site Work 180, the R&D leader says a personal loss fueled her passion to innovate for patients.
Dr. Guthrie and Neonatal Screening Day 2022
Before Dr. Robert Guthrie, hospitals did not routinely test babies for serious health problems. Rare disease advocates chose …